ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,326Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 434

$569K Total Retail Price of All Prescriptions

Rank: 27 out of 434

772 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 772 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 772 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 598 490 1 2
LISINOPRIL 561 491 2 1
HYDROCODONE-ACETAMINOPHEN 494 353 S3 3 4
OMEPRAZOLE 479 399 4 5
AMLODIPINE BESYLATE 412 378 5 6
LEVOTHYROXINE SODIUM 377 328 6 3
METFORMIN HCL 296 267 7 7
ZOLPIDEM TARTRATE 282 234 8 11
LOVASTATIN 240 220 9 10
METOPROLOL TARTRATE 237 226 10 12
FUROSEMIDE 210 171 11 9
ATENOLOL 201 163 12 16
GABAPENTIN 184 134 13 14
HYDROCHLOROTHIAZIDE 182 164 14 8
WARFARIN SODIUM 173 159 15 18
LOSARTAN POTASSIUM 168 137 16 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 161 140 17 21
PRAVASTATIN SODIUM 155 140 18 17
SPIRIVA 125 95 19 36
METOPROLOL SUCCINATE 124 96 20 22
ALENDRONATE SODIUM 121 116 21 15
PREDNISONE 112 97 22 42
POTASSIUM CHLORIDE 111 85 23 20
AZITHROMYCIN 108 84 24 38
CARVEDILOL 92 84 25 24
ADVAIR DISKUS 88 70 26 52
FLUOXETINE HCL 86 44 27 32
CIPROFLOXACIN HCL 84 74 28 55
PROAIR HFA 84 54 28 60
TRIAMTERENE-HCTZ 79 76 30 47
FLUTICASONE PROPIONATE 79 57 30 26
RANITIDINE HCL 79 63 30 31
IBUPROFEN 78 57 33 56
VENTOLIN HFA 77 47 34 30
ALLOPURINOL 75 68 35 25
TRICOR 73 59 36 141
TAMSULOSIN HCL 72 72 37 29
BENAZEPRIL HCL 71 71 38 49
GLYBURIDE 70 53 R 39 51
DILTIAZEM 24HR CD 68 53 40 126
DIGOXIN 68 55 40 69
ATORVASTATIN CALCIUM 67 66 42 19
GEMFIBROZIL 67 59 42 62
SERTRALINE HCL 64 45 44 27
CITALOPRAM HBR 62 43 45 23
LOSARTAN-HYDROCHLOROTHIAZIDE 61 51 46 39
CLOPIDOGREL 61 51 46 41
TRIAMCINOLONE ACETONIDE 57 36 48 94
PANTOPRAZOLE SODIUM 55 34 49 66
CLONIDINE HCL 55 32 49 63
ESTRADIOL 51 28 R 51 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.